Can Innovation Solve the Healthcare Economics Crisis? Panel Notes

Can medical technology innovation solve the healthcare economics crisis? Read summary notes from this MDG Boston panel discussion

Perspectives on Medical Reimbursement By JR Associates   Recently, our VP of Global Health Policy, Jo Ellen Slurzberg moderated a compelling roundtable discussion at MDG Boston, a leading member-based community for medical device and technology professionals. This session focused on one of the industry’s most formidable issues: U.S. Healthcare Economics – Innovating Our Way Out of a…

Read More »

MDMA Reimbursement Conference Notes: 2018

MDMA Reimbursement Conference Notes 2018

Perspectives on Medical Reimbursement By JR Associates Among our consultants, the MDMA Coverage, Reimbursement and Health Policy Conference is more than just another event on the business calendar. For us, it is an important professional tradition that began 21 years ago. That’s when our President, Judy Rosenbloom, and VP of Global Health Policy, Jo Ellen…

Read More »

Rethinking Global Health Innovation Education: GENiE Conference Notes

Global Health Innovation Educators GENiE Notes - Learn how top business schools are educating tomorrow's healthcare innovators

Perspectives on Medical Reimbursement By JR Associates In today’s highly complex healthcare environment, what’s the best way to prepare the next generation of life science innovators? This central question is often top-of-mind among members of the Global Educators Network for Health Innovation Education (GENiE Group). It also provides an overarching framework for the GENiE annual…

Read More »

Medical Device Reimbursement: ReGARDD Forum Notes

ReGARDD medical device and drug research forum notes

Perspectives on Medical Reimbursement By JR Associates What should medical device researchers know about premarket FDA submissions? And what should they understand about reimbursement in early stages of product development?  These core questions inspired the first educational seminar hosted by ReGARDD (Regulatory Guidance for Academic Research of Drugs and Devices) in April 2017, where our…

Read More »

How Can Medical Innovators Build a Case for Reimbursement?

Perspectives on Medical Reimbursement By JR Associates Coverage. Coding. Payment. These three factors deeply influence reimbursement for every new medical technology product. But there are no “cookie cutter” solutions. Because the reimbursement landscape is so complex and time consuming, it’s smart to start preparing for reimbursement as early as possible in the business planning and product development process. But…

Read More »

Biomoda Readies Products To Assist Insurer Reimbursement

Outsourcing Partner Speeds Entry Into Commercial Cancer Detection and Treatment Market Albuquerque, N.M. — (Business Wire), June 30, 2004 — Biomoda, Inc. announced today that it has contracted with reimbursement consulting firm, JR Associates, to help advance Biomoda’s patented biopharmaceutical products. Primarily, JR Associates consultants will investigate the potential for securing positive coverage, coding, and payment by Medicare and commercial…

Read More »